The impact of the COVID-19 pandemic on antimicrobial usage: an international patient-level cohort study.
Farzana R, Harbarth SJ, Yu LM, Carretto E, Moore CE, Feasey NA, Gales AC, Galal U, Ergonul O, Yong D, Yusuf MA, Veeraraghavan B, Iregbu KC, van Santen JA, Ribeiro ACDS, Fankhauser CM, Chilupsya CJ, Dolecek C, Ferreira DB, Pinarlik F, Jang J, Gücer LS, Cavazzuti L, Sultana M, Haque MDN, Haddad MG, Medugu N, Nwajiobi-Princewill PI, Marrollo R, Zhao R, Baskaran VB, Peter JV, Chandy SJ, Bakthavatchalam YD, Walsh TR; COVID-19/DRI Study Group.
Farzana R, et al.
JAC Antimicrob Resist. 2025 Mar 26;7(2):dlaf037. doi: 10.1093/jacamr/dlaf037. eCollection 2025 Apr.
JAC Antimicrob Resist. 2025.
PMID: 40151230
Free PMC article.